Sterile Compounders Would Get Tailored Manufacturing Regs If FDA Gets New Authority

FDA’s Woodcock says large-scale compounders would not be subject to all current Good Manufacturing Practices, but would be given separate regulations tailored specifically for them, similar to how it handled PET drug requirements.